health
Federal health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora.
The outbreak included 72 people as of Wednesday.
The Food and Drug Administration has not yet identified which products are linked to the illnesses. Officials also have not said where the cases are located....
Read More
By the Numbers: This year’s Ebola outbreak has spread faster than the worst on record
ABUJA, Nigeria (AP) — The Ebola outbreak in Congo has killed over 1,000 people, reaching the grim milestone nearly three times faster than the 2014-2016 Ebola epidemic that is considered the worst on record.
Data from Congo’s Ministry of Health shows that as of Tuesday, the...
Read More
Biking to work: Tips to get started, stay safe and look presentable when you arrive
NEW YORK (AP) — When 72-year-old Michael Roper rides his bicycle to and from the pub he owns in Chicago, he can’t imagine a better way to commute. He’s getting exercise, drifting through fresh air and catching glimpses of neighborhood life — a recently opened...
Read More
health Headlines
Famine has ended in Gaza. But the gains are fragile and it could get worse- Lettuce samples at Taylor Farms negative for cyclospora, Mexican authorities say
- Giant metal roosters spread autism acceptance in Maine after town zoning spat
- FDA advisory panel votes to place popular peptide TB-500 on compounding list
- Edwards Lifesciences beats quarterly estimates on strong demand for heart devices
- GE HealthCare says CFO Saccaro to step down; reports preliminary Q2 results
- Democrats say Social Security boss’ message pushed misleading statements on Trump tax law’s benefits
- Senate committee postpones vote on whether to advance CDC director nominee
- FDA panel votes to place popular peptide BPC-157 on compounding list
- FDA advisers back first four of seven unapproved peptides under review for looser rules
- Taylor Farms temporarily shuts Mexico processing facility as U.S. cyclosporiasis cases rise, source says
- Senator backs Trump CDC pick Schwartz, boosting path to confirmation
- What experts are saying as Ebola outbreak in Congo and Uganda kills more than 1,000 people
- Quest Diagnostics raises annual forecast on testing demand
- Cigna says AI tools to save customers $200 million in medical expenses over three years
- BeOne announces $300 million expansion of US manufacturing facility
- Hungary’s government scraps VAT on subscription drugs
- Lilly announces more next-gen obesity drug data, plans Q1 2027 FDA application
- West Pharma raises profit forecast on strong demand for injectable drug components
- Thermo Fisher raises annual profit forecast as customer demand improves
- Molina plummets as it expects to halve its Obamacare presence
- Analysis-Hims & Hers stands to gain if the FDA loosens restrictions on peptides
- Congo’s Ebola deaths top 1,000 as violence and shortages hamper medics
- Indonesia’s tobacco industry protests plan to toughen rules
- India’s Cipla posts another profit decline, names insider Dinesh Jain CFO
- What a reporter learned covering the impact of USAID cuts on aid workers-turned-sex workers in Nepal
- PHOTO ESSAY: By a dark, dangerous highway in Nepal, aid workers fired by USAID cuts turn to sex work
- What to know from the AP’s report on the impact of USAID cuts on impoverished aid workers in Nepal
- Sex work or starve: Aid workers in Nepal left jobless by USAID cuts turn to sex work to survive
- Poultry firm recalls nearly 1.6 million dozen eggs over potential salmonella, US FDA says
- AI shortens drug discovery to around 1 year in China, Insilico CEO says
- Argenx’s Vyvgart sales jump in second quarter, shares climb
- Sartorius says growth to come in lower half of guidance range
- FDA panel narrowly backs unapproved peptide drugs favored by RFK Jr. and wellness influencers
- Roche confirms outlook despite Vabysmo miss, currency headwinds
- Indian drugmaker Dr Reddy’s slips on margin, semaglutide supply woes
- Judge questions difference between Hegseth’s testosterone policy and transgender care for troops
- Hair loss with GLP-1 drugs is rare, but real, studies find
- Molina’s profit forecast lift overshadowed by Obamacare weakness
- Pfizer’s prostate cancer drug combination gets US FDA priority review
- US judge casts doubt on 69,000 cases alleging J&J talc caused cancer
- US FDA says it is investigating another cyclosporiasis outbreak
- Generic drug sector seeks policy fixes after Trump tariff threat
- GSK enters lung cancer drug market with early FDA nod for Jideytro
- Cyclosporiasis cases in Michigan climb to over 7,000, state health officials say
- France records 5,764 excess deaths during June-July heatwaves, health agency reports
- US quarantined citizens at New York military base after return from Congo, sources say
- Health Rounds: New cardiac guidelines mean more statins for more people, study finds
- FDA panel to review popular peptides amid persistent consumer appetite
- Philip Morris to lift Zyn investment, cigarette demand drives earnings beat
